InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,301.57
(
0.64%
)
US TECH 100
18,356.60
(
1.16%
)
Dow Jones
39,136.71
(
0.18%
)
Brent Oil
81.73
(
0.51%
)
Bitcoin
68,190.28
(
0.39%
)
Post# of 7503
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Dennboy66

Send PM Follow Ignore
Followers 4
Posts 120
Boards Moderated 0
Alias Born 04/14/2021

Dennboy66

Re: None

Saturday, 05/11/2024 12:18:23 AM

Saturday, May 11, 2024 12:18:23 AM

Post# of 7503
Looks like the therapeutics team had their launch meeting.

https://www.linkedin.com/company/revance

Scroll down. And you can see the group.

Having sold neurotoxins before, I bet that they do well. There is a real need for a longer lasting therapy.

And the therapeutic world is so much different than aesthetic. MDs are interested in outcomes and what is best for their patients and are not influenced by how much they make. They just don’t want to lose money as it is a buy and bill.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent RVNC News
More RVNC News
InvestorsHub NewsWire

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

Start posting your company's news
Only $200 per official company press release!